SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.834
EU - Europa 5.107
AS - Asia 4.097
SA - Sud America 730
Continente sconosciuto - Info sul continente non disponibili 605
AF - Africa 77
OC - Oceania 13
Totale 16.463
Nazione #
US - Stati Uniti d'America 5.693
SG - Singapore 1.563
IE - Irlanda 1.390
CN - Cina 1.105
RU - Federazione Russa 910
HK - Hong Kong 676
SE - Svezia 652
BR - Brasile 577
UA - Ucraina 539
IT - Italia 528
FR - Francia 340
VN - Vietnam 266
DE - Germania 248
IN - India 146
FI - Finlandia 130
GB - Regno Unito 121
BD - Bangladesh 83
TR - Turchia 77
AR - Argentina 58
CA - Canada 55
MX - Messico 45
CZ - Repubblica Ceca 40
NL - Olanda 36
PL - Polonia 34
IQ - Iraq 29
ZA - Sudafrica 27
ES - Italia 25
AT - Austria 23
VE - Venezuela 22
ID - Indonesia 21
EC - Ecuador 20
BE - Belgio 19
JP - Giappone 17
CL - Cile 14
AU - Australia 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
PY - Paraguay 12
EU - Europa 11
GR - Grecia 11
KE - Kenya 11
PE - Perù 11
SA - Arabia Saudita 11
CR - Costa Rica 10
PK - Pakistan 10
CO - Colombia 9
EG - Egitto 9
LT - Lituania 9
JO - Giordania 8
MA - Marocco 8
BA - Bosnia-Erzegovina 7
AZ - Azerbaigian 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
LB - Libano 6
LV - Lettonia 6
AM - Armenia 5
DZ - Algeria 5
ET - Etiopia 5
IL - Israele 5
IR - Iran 5
AL - Albania 4
DK - Danimarca 4
GT - Guatemala 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NO - Norvegia 4
RO - Romania 4
BG - Bulgaria 3
BO - Bolivia 3
NP - Nepal 3
PH - Filippine 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BH - Bahrain 1
Totale 15.861
Città #
Dublin 1.389
San Jose 1.296
Singapore 745
Hong Kong 676
Ashburn 491
Chandler 487
Nyköping 481
Jacksonville 365
Dallas 251
Beijing 234
Santa Clara 229
Dearborn 222
New York 213
Lauterbourg 172
Council Bluffs 170
Nanjing 168
Princeton 142
Moscow 141
Munich 113
The Dalles 102
Wilmington 92
Ho Chi Minh City 86
Nanchang 78
Columbus 74
Los Angeles 72
Helsinki 68
São Paulo 62
Shenyang 53
San Mateo 52
Hanoi 49
Rome 47
Bari 44
Milan 44
Ann Arbor 40
Boardman 39
Tianjin 28
Foggia 27
Hebei 27
Warsaw 27
Frankfurt am Main 25
London 25
Brno 24
Brooklyn 24
Jiaxing 24
Shanghai 24
Kunming 23
Nuremberg 23
Pune 23
Jinan 22
Rio de Janeiro 22
Guangzhou 21
Chicago 20
Hangzhou 20
Changsha 19
Des Moines 19
Turku 19
Brussels 18
Seattle 18
Belo Horizonte 17
San Francisco 17
Montreal 16
Orem 16
Chennai 15
Tokyo 15
Haiphong 14
Naples 14
Mexico City 13
Olomouc 13
Washington 13
Falkenstein 12
Tashkent 12
Vienna 12
Baghdad 11
Brasília 11
Da Nang 11
Hillsboro 11
Reading 11
Zhengzhou 11
Düsseldorf 10
Jakarta 10
Johannesburg 10
Phoenix 10
San José 10
Taizhou 10
Toronto 10
Boston 9
Guayaquil 9
Ningbo 9
Norwalk 9
Porto Alegre 9
Thái Nguyên 9
Assago 8
Atlanta 8
Borås 8
Chengdu 8
Denver 8
Lima 8
Manchester 8
Redwood City 8
Woodbridge 8
Totale 9.970
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 225
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 222
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 201
A recurrent epidermoid cyst of the spleen: report of a case and literature review 180
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 175
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 162
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 162
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 161
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 154
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 151
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 150
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 147
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 146
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 143
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 142
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 141
Surgicel (R) granuloma mimicking ovarian cancer: A case report 140
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 139
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 136
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 134
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 134
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 133
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 133
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 131
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 130
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 129
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 129
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 128
Role of age in prostate and bladder cancer. A critical overview 128
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 126
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 125
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 125
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 125
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 125
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 124
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 121
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 121
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 115
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 114
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 114
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 113
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 113
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 112
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 112
Surgicel® granuloma mimicking ovarian cancer: A case report 111
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 110
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 110
Daily tadalafil for the chronic phase of stuttering priapism: A case report 110
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre series 108
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 108
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 107
p-NFkB expression in thyroid cancer. 105
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 105
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 105
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 104
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 103
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 101
Pilonidal cyst of the penis mimicking carcinoma. 100
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 100
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 100
Asymptomatic bladder metastasis from breast cancer. 99
Magnetic resonance imaging of penile paraffinoma: Case report 99
Modulation of complement activation by pentraxin-3 in prostate cancer 99
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 99
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 99
N-cadherin up-regulation in aggressive oral squamous cell carcinoma. 98
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 98
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 98
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 96
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 95
Molecular markers in bladder cancer: Novel research frontiers 95
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 93
Prostate cancer biomarkers: a practical review based on different clinical scenarios 93
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 92
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 92
Elderly patients and prostate biopsy. How old is too old? 91
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  91
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma 90
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 90
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 90
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 89
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 89
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 87
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 87
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 86
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 85
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience 85
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 84
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 84
Micropapillary bladder cancer, a variant histology of the elderly 83
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 83
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 83
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update 82
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 81
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 81
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 79
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 78
Assessing PD-L1 Expression in Different Tumor Types 78
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables 77
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 76
Totale 11.412
Categoria #
all - tutte 101.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022747 0 12 38 12 45 9 93 60 101 150 27 200
2022/20233.001 262 181 146 107 144 230 10 222 1.532 44 55 68
2023/2024823 83 37 36 20 40 283 72 38 10 23 41 140
2024/20253.205 151 51 131 62 95 360 311 141 795 457 306 345
2025/20265.628 365 442 647 745 298 233 1.121 641 365 400 164 207
2026/2027411 132 279 0 0 0 0 0 0 0 0 0 0
Totale 16.463